Caution is Required During Active Chemotherapy and Immunotherapy While the benefits in the survivorship setting are promising, Iyengar highlighted a note of caution for patients currently undergoing intensive active treatment
Abstract #1402779: a case of possible tirzepatide-induced pancreatitis
Its a scientific clich: more research needed
Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, Bain V, Heathcote J, Zeuzem S, Trepo C, Albrecht J, for The International Hepatitis Interventional Therapy Group: Randomised trial of interferon 2b plus ribavirin for 48 weeks or for 24 weeks versus interferon 2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
There, it encourages your pancreas to release insulin
The timeframe for recent varies by cancer type, stage at diagnosis, and individual factors